SENTINEXT THERAPEUTICS ApS: Financial statements 2012
CVR: 32473016
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
SENTINEXT THERAPEUTICS ApS (CVR 32473016) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 1,404,825 and a net result of DKK 20,007. Equity in the 2012 report amounted to DKK 85,845. The solvency ratio was 12.5%.
- Gross Profit
- DKK 1,404,825
- Profit/Loss
- DKK 20,007
- Equity
- DKK 85,845
- Total Assets
- DKK 685,343
Official annual report
Keep an eye on SENTINEXT THERAPEUTICS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout SENTINEXT THERAPEUTICS ApS
SENTINEXT THERAPEUTICS ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2009. The company has been dissolved on 15 November 2013. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 0 employees (2013). In 2013, the company reported a gross profit of DKK 762,450 and a net result of DKK 36,765 compared with DKK 20,007 the year before. Equity in the 2013 report amounted to DKK 122,610.